VRTX - Company ID 0000875320
The table below shows VERTEX PHARMACEUTICALS INC / MA's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.08B | $4.57B | $10.37B | $10.50B | $6.79B | $5.99B |
| Short-term investments | $1.52B | $1.55B | $849.20M | $274.50M | $729.90M | $670.71M |
| Receivables | $2.05B | $1.61B | $1.56B | $1.44B | $1.14B | $885.35M |
| Inventory | $1.69B | $1.21B | $738.80M | $460.60M | $353.10M | $280.78M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $11.20B |
| $9.60B |
| $14.14B |
| $13.23B |
| $9.56B |
| $8.13B |
| Property, plant & equipment | - | - | - | - | - | - |
| Goodwill | $1.09B | $1.09B | $1.09B | $1.09B | $1.00B | $1.00B |
| Total assets | $25.64B | $22.53B | $22.73B | $18.15B | $13.43B | $11.75B |
| Accounts payable | $461.70M | $413.00M | $364.90M | $303.90M | $195.00M | $155.14M |
| Total current liabilities | $3.86B | $3.56B | $3.55B | $2.74B | $2.14B | $1.88B |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $6.98B | $6.12B | $5.15B | $4.24B | $3.33B | $3.06B |
| Retained earnings | $13.56B | $9.61B | $10.14B | $6.52B | $3.20B | $858.67M |
| Total equity | $18.67B | $16.41B | $17.58B | $13.91B | $10.10B | - |